NCT01641315View on ClinicalTrials.gov

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Rabies
Interventions
BIOLOGICAL

rabies vaccine

"Group 1: rabies vaccination was given to rabies exposed victims on day 0,3,7,14,28 with ERIG on day 0.~Group 2: rabies vaccination was given to healthy volunteers on day 0,3,7,14 with ERIG on day 0.~Group 3: rabies vaccination was given to healthy volunteers on day 0,3,7,28 with ERIG on day 0."

Trial Locations (1)

10330

Queen Saovabha Memorial Institute, Bangkok

All Listed Sponsors
lead

Queen Saovabha Memorial Institute

OTHER

NCT01641315 - Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins | Biotech Hunter | Biotech Hunter